Heart failure is a life‐threatening disease and addressing it should be considered a global
health priority. At present, approximately 26 million people worldwide are living with heart …

Background Poor adherence to medications is a common problem among heart failure (HF)
patients. Inadequate adherence leads to increased HF exacerbations, reduced physical …

Measurement of natriuresis has been suggested as a reliable, easily obtainable biomarker
for assessment of the response to diuretic treatment in patients with acute heart failure …

Background: Sodium-glucose cotransporter-2 inhibitors improve heart failure–related
outcomes. The mechanisms underlying these benefits are not well understood, but diuretic …

Importance It remains unclear whether telemonitoring approaches provide benefits for
patients with heart failure (HF) after hospitalization. Objective To evaluate the effectiveness …

Aims The aim of this study was to assess the net clinical and prognostic effects of
intravenous (iv) iron therapy in patients with systolic heart failure (HF) and iron deficiency …

Heart failure (HF) is a growing healthcare burden and one of the leading causes of
hospitalizations and readmission. Preventing readmissions for HF patients is an increasing …

The prevalence of patients with concomitant heart failure (HF) and diabetes mellitus (DM)
continues to increase with the general aging of the population. In patients with chronic HF …

Background Serelaxin is a recombinant form of human relaxin-2, a vasodilator hormone that
contributes to cardiovascular and renal adaptations during pregnancy. Previous studies …

Despite available therapy, mortality and readmission rates within 60–90 days of discharge
for patients hospitalized with heart failure (HF) approach 15% and 30%, respectively. This …